MindMaze Therapeutics Reports 2026 Half-Year Results and Corporate Update

GENEVA, Aug. 27, 2026 /PRNewswire/ — MindMaze Therapeutics Holding SA (SIX: MMTX) (MindMaze Therapeutics, or the Company), a global leader in scalable precision neurotherapeutics, today announced the publication of its 2026...